US-mRNA may be useful for purposes of biomarker identification aimed at improving clinical precision in the diagnosis and treatment of diseases, including states of excess MR activation, such as many instances of resistant hypertension. The gene discussed is NR3C2; the disease is Hypertension resistant to conventional therapy.